Edwards Larry Todd (See Remarks) sold Arcutis Biotherapeutics ($ARQT) shares seven times on the open market over the past year, for a total of $1.07 million. His most recent sale occurred on March 2, 2026. These sales rank 4,751st among 11,678 individual insiders, below the average of $8.6 million per seller and 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Arcutis Biotherapeutics, Inc. | $ARQT | Edwards Larry Todd | See Remarks | A | Stock Option (right to buy) | 77000 | $0.00 | 77,000.0000 | 132,885,000 | 9999.99% | 0.06% |
| March 2, 2026 | Arcutis Biotherapeutics, Inc. | $ARQT | Edwards Larry Todd | See Remarks | S | Common Stock | 103 | $25.91 | 175,178.0000 | 132,885,000 | 0.06% | 0.00% |
| March 2, 2026 | Arcutis Biotherapeutics, Inc. | $ARQT | Edwards Larry Todd | See Remarks | S | Common Stock | 3584 | $25.16 | 175,281.0000 | 132,885,000 | 2.00% | 0.00% |
| Feb. 27, 2026 | Arcutis Biotherapeutics, Inc. | $ARQT | Edwards Larry Todd | See Remarks | A | Common Stock | 30000 | $0.00 | 178,865.0000 | 132,885,000 | 20.15% | 0.02% |
| Feb. 2, 2026 | Arcutis Biotherapeutics, Inc. | $ARQT | Edwards Larry Todd | See Remarks | S | Common Stock | 2052 | $25.50 | 148,865.0000 | 132,885,000 | 1.36% | 0.00% |
| Nov. 6, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Edwards Larry Todd | See Remarks | S | Common Stock | 29131 | $25.16 | 150,193.0000 | 132,885,000 | 16.24% | 0.02% |
| Oct. 2, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Edwards Larry Todd | See Remarks | S | Common Stock | 297 | $20.78 | 179,324.0000 | 132,885,000 | 0.17% | 0.00% |
| Oct. 2, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Edwards Larry Todd | See Remarks | S | Common Stock | 4207 | $19.99 | 178,897.0000 | 132,885,000 | 2.30% | 0.00% |
| May 19, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Edwards Larry Todd | See Remarks | S | Common Stock | 7451 | $14.07 | 183,104.0000 | 120,957,633 | 3.91% | 0.01% |
| Feb. 28, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Edwards Larry Todd | See Remarks | A | Common Stock | 38000 | $0.00 | 173,555.0000 | 120,957,633 | 28.03% | 0.03% |
| Feb. 28, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Edwards Larry Todd | See Remarks | A | Common Stock | 17000 | $0.00 | 190,555.0000 | 120,957,633 | 9.80% | 0.01% |
| Feb. 28, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Edwards Larry Todd | See Remarks | A | Stock Option (right to buy) | 99000 | $0.00 | 99,000.0000 | 120,957,633 | 9999.99% | 0.08% |
| Feb. 28, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Edwards Larry Todd | See Remarks | A | Stock Option (right to buy) | 43000 | $0.00 | 43,000.0000 | 120,957,633 | 9999.99% | 0.04% |
| Feb. 3, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Edwards Larry Todd | See Remarks | S | Common Stock | 2173 | $12.70 | 135,555.0000 | 120,957,633 | 1.58% | 0.00% |
| Nov. 30, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Edwards Larry Todd | See Remarks | P | Common Stock | 1093 | $7.11 | 137,728.0000 | 124,302,317 | 0.80% | 0.00% |
| Oct. 2, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Edwards Larry Todd | SVP Chief Commercial Officer | S | Common Stock | 3725 | $10.01 | 136,635.0000 | 124,302,317 | 2.65% | 0.00% |
| May 17, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Edwards Larry Todd | SVP Chief Commercial Officer | S | Common Stock | 7640 | $8.98 | 140,360.0000 | 69,305,487 | 5.16% | 0.01% |
| May 16, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Edwards Larry Todd | SVP Chief Commercial Officer | A | Common Stock | 60000 | $0.00 | 148,000.0000 | 69,305,487 | 68.18% | 0.09% |
| Jan. 12, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Edwards Larry Todd | Chief Commercial Officer | A | Stock Option (right to buy) | 176000 | $0.00 | 176,000.0000 | 69,305,487 | 9999.99% | 0.25% |
| Jan. 12, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Edwards Larry Todd | Chief Commercial Officer | A | Common Stock | 28000 | $0.00 | 88,000.0000 | 69,305,487 | 46.67% | 0.04% |